Keyword: Minoryx Therapeutics
The round sets Minoryx up to expand clinical development of PPAR-gamma agonist MIN-102.
In our EuroBiotech roundup this week, biotechs file to raise $300 million, Minoryx spins off platform and Galapagos, MorphoSys post clinical data.
NeuroVia gets $14 million to treat rare CNS disorder X-linked adrenoleukodystrophy.
